No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons

LeGoff, Jerome; Tanton, Clare; Delaugerre, Constance; More

AIDS . 24(16):2595-2596, October 23, 2010.

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

Delany, Sinéad; Mlaba, Nonkululeko; Clayton, Tim; More

AIDS . 23(4):461-469, February 20, 2009.

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

Landau, Alain; Batisse, Dominique; Piketty, Christophe; More

AIDS . 15(16):2149-2155, November 9, 2001.

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

Landau, Alain; Batisse, Dominique; Huyen, Jean Paul Duong Van; More

AIDS . 14(7):839-844, May 5, 2000.

Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including...

Piketty, Christophe; Race, Esther; Castiel, Philippe; More

AIDS . 14(5):626-628, March 31, 2000.

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease...

Piketty, Christophe; Race, Esther; Castiel, Philippe; More

AIDS . 13(11):F71-F77, July 30, 1999.

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

Piketty, Christophe; Castiel, Philippe; Belec, Laurent; More

AIDS . 12(7):745-750, May 7, 1998.